5-ASA exerts its anti-inflammatory effects via the activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ), a nuclear receptor highly expressed in colonic epithelial cells, whose signalling is otherwise impaired in IBD [49]. Here, PPARG is linked to inflammatory bowel disease.